Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Rapid Micro Biosystems ( (RPID) ) has issued an announcement.
On August 8, 2025, Rapid Micro Biosystems entered into a Loan and Security Agreement with Trinity Capital Inc., securing a $45 million term loan facility to bolster its financial position and support long-term growth. The company reported a 10% increase in total revenue for the second quarter of 2025 compared to the previous year, driven by strong performance in service and product revenue, and reaffirmed its full-year revenue guidance of at least $32 million.
The most recent analyst rating on (RPID) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Rapid Micro Biosystems stock, see the RPID Stock Forecast page.
Spark’s Take on RPID Stock
According to Spark, TipRanks’ AI Analyst, RPID is a Neutral.
Rapid Micro Biosystems shows strong revenue growth and improvement in gross margins, which are the most significant strengths. However, the company faces considerable profitability and cash flow challenges, impacting its financial health. Technical analysis suggests moderate performance, while valuation metrics highlight concerns due to unprofitability. Positive guidance from the earnings call provides some optimism, but the overall stock score reflects the need for operational improvements.
To see Spark’s full report on RPID stock, click here.
More about Rapid Micro Biosystems
Rapid Micro Biosystems is an innovative life sciences technology company that provides automation solutions for efficient manufacturing and the fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Their flagship Growth Direct system automates microbial quality control testing, enhancing accuracy, efficiency, and compliance in pharmaceutical manufacturing.
Average Trading Volume: 96,349
Technical Sentiment Signal: Buy
Current Market Cap: $142.9M
For a thorough assessment of RPID stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money